Variant report
Variant | nsv945682 |
---|---|
Chromosome Location | chr1:239349880-239355435 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:239347033..239349872-chr1:239353047..239355159,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs573888607 | chr1:239349881-239349882 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534761609 | chr1:239349956-239349957 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs12044393 | chr1:239349982-239349983 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2664055 | chr1:239349993-239349994 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs546214423 | chr1:239350009-239350010 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs373514287 | chr1:239350011-239350012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs576359251 | chr1:239350079-239350080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543776102 | chr1:239350082-239350083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs367973199 | chr1:239350108-239350109 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562006421 | chr1:239350137-239350138 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181297729 | chr1:239350147-239350148 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547585800 | chr1:239350150-239350151 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs559065978 | chr1:239350196-239350197 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532862768 | chr1:239350224-239350225 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs146389589 | chr1:239350266-239350267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533965243 | chr1:239350274-239350275 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559613822 | chr1:239350341-239350342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs79834689 | chr1:239350350-239350351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537009103 | chr1:239350437-239350438 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186545889 | chr1:239350449-239350450 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567561747 | chr1:239350462-239350463 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2664056 | chr1:239350538-239350539 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs553187660 | chr1:239350545-239350546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111280443 | chr1:239350640-239350641 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2664057 | chr1:239350728-239350729 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs558198619 | chr1:239350743-239350744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs16837972 | chr1:239350770-239350771 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 17060936 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Arrhythmogenic right ventricular cardiomyopathy | 17576883 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:239345800-239350800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr1:239347200-239350800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr1:239348200-239350000 | Active TSS | Liver | Liver |